Topical progesterone as support for the luteal phase in induced cycles

e efficacy and tolerability of 2.5% natural vaginal progesterone as luteal phase support in pharmacologically induced cycles has been evaluated. On the basis of the administered therapy, the population studied was subdivided at random into four different groups. Sixty patients came to the Sterility...

Full description

Saved in:
Bibliographic Details
Published inMinerva ginecologica Vol. 49; no. 7-8; p. 361
Main Authors Zaffaroni, L, Costa, P, Vinci, G W
Format Journal Article
LanguageItalian
Published Italy 01.07.1997
Subjects
Administration, Topical
Adult
Endometrium - diagnostic imaging
Female
Humans
Infertility, Female - drug therapy
Luteal Phase - drug effects
Ovulation Induction
Progesterone - administration & dosage
Progesterone - blood
Progesterone - pharmacology
Ultrasonography
Vagina
Online AccessGet more information

Cover

More Information
Summary:e efficacy and tolerability of 2.5% natural vaginal progesterone as luteal phase support in pharmacologically induced cycles has been evaluated. On the basis of the administered therapy, the population studied was subdivided at random into four different groups. Sixty patients came to the Sterility Autonomous Department of the Niguarda Ca' Granda Hospital in Milan from November 1994 to January 1996. Both ultrasonographic and plasmatic hormonal parameters have been evaluated on a monthly basis. The plasma progesterone levels and ultrasonographic endometrial thickness average values resulted more important in groups treated with topical progesterone; in these same groups a greater percentage of pregnancies was observed. The results obtained demonstrated that the drug studied can be recommended as a valid luteal phase support in pharmacologically induced cycles.
ISSN:0026-4784